General Information
Revision date
2020-01-16
Product name
Lovastatin Tablets USP
Manufacturer Name
Lupin Limited
Icons in SDS
Company Information
company name
Lupin Limited
Section 2
SECTION 2: Hazards identification
Fire and Explosion Health Expected to be non-combustible. Hypersensitivity to any component of this medication. Active liver disease or unexplained persistent elevations of serum transaminases. Concomitant administration with strong CYP3A4 inhibitors (e.g., itraconazole, ketoconazole, posaconazole, voriconazole, HIV protease inhibitors, boceprevir, telaprevir, erythromycin, clarithromycin, telithromycin, nefazodone, and cobicistat-containing products)
Environmental hazards
No information is available about the potential of this product to produce adverse environmental effects.
